Literature DB >> 12612975

An index for renal outcome in ANCA-associated glomerulonephritis.

Clarissa E Vergunst1, Eveline van Gurp, E Christiaan Hagen, Hans C van Houwelingen, Herbert A Hauer, Laure-Hélène Noël, Rüdiger Waldherr, Franco Ferrario, Fokko J van der Woude, Jan A Bruijn, Ingeborg M Bajema.   

Abstract

BACKGROUND: The aim of this study is to analyze the predictive value of clinical, serological, and histological parameters for renal outcome in antineutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis by multivariate analysis and create an index valid for clinical use.
METHODS: Data from 160 patients with Wegener's granulomatosis, microscopic polyangiitis, and idiopathic rapidly progressive glomerulonephritis without immune deposits (renal-limited vasculitis) were collected. The Cockcroft formula was used to assess renal function expressed by glomerular filtration rate (GFR) at the time of renal biopsy (t = 0) and 1 year later (t = 1). Other clinical parameters were age, sex, and diagnosis. ANCA test results were scored as cytoplasmic ANCA/antiproteinase 3 (anti-PR3) or perinuclear ANCA/antimyeloperoxidase (anti-MPO) positive or negative. Histological data included normal glomeruli, fibrinoid necrosis, extracapillary proliferation, granulomas, interstitial edema, focal and diffuse infiltrates, fibrosis, tubular cylinders/casts, tubular atrophy, tubular necrosis, sclerosis, mesangial proliferation, mesangial matrix expansion, arteriosclerosis, and infiltrates in arterioles. In a separate analysis, we explored whether there were histological differences between patients with anti-PR3 and anti-MPO ANCA test results.
RESULTS: Forty percent of the variation in renal function at the time of biopsy can be explained by the presence or absence of tubular atrophy, normal glomeruli, fibrinoid necrosis, extracapillary proliferation, and age. Renal function at the time of biopsy is the best predictor for renal function at t = 1 in patients with ANCA-associated glomerulonephritis. Together with normal glomeruli, fibrinoid necrosis, and age, it explains more than 60% of the variation in GFR at t = 1. ANCA subtype has no independent contribution in predicting patient prognosis. Results translated into a clinically relevant index: GFR at t = 1 = 36.96 + 0.65* (GFR at t = 0) + 10.52 (if normal glomeruli present) + 7.72 (if fibrinoid necrosis present) - 0.42* (age).
CONCLUSION: The index created with results from this study provides an indication of renal outcome in patients diagnosed with ANCA-associated glomerulonephritis. Copyright 2003 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612975     DOI: 10.1053/ajkd.2003.50115

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

Review 1.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

Review 2.  Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.

Authors:  I M Bajema
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

Review 3.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

4.  Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.

Authors:  Emilie C Rijnink; Y K Onno Teng; Suzanne Wilhelmus; Mathilde Almekinders; Ron Wolterbeek; Karlien Cransberg; Jan A Bruijn; Ingeborg M Bajema
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 8.237

5.  Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.

Authors:  Matija Crnogorac; Ivica Horvatic; Luka Toric; Danica Galesic Ljubanovic; Miroslav Tisljar; Krešimir Galesic
Journal:  Int Urol Nephrol       Date:  2017-06-23       Impact factor: 2.370

Review 6.  Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan.

Authors:  Kensuke Joh; Eri Muso; Hidekazu Shigematsu; Masato Nose; Michio Nagata; Yoshihiro Arimura; Wako Yumura; Takashi Wada; Kousaku Nitta; Hirofumi Makino; Yoshio Taguma; Hidetoshi Kaneoka; Yuhsuke Suzuki; Masaki Kobayashi; Akio Koyama; Joichi Usui; Hiroshi Hashimoto; Shoichi Ozaki; Yasuhiko Tomino; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-04-22       Impact factor: 2.801

7.  Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.

Authors:  Godasi S R S N K Naidu; Aman Sharma; Ritambra Nada; Harbir Singh Kohli; Vivekanand Jha; Krishan Lal Gupta; Vinay Sakhuja; Manish Rathi
Journal:  Rheumatol Int       Date:  2014-05-18       Impact factor: 2.631

8.  Pathology of ANCA-associated vasculitis.

Authors:  Franco Ferrario; Alice Vanzati; Fabio Pagni
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

9.  ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.

Authors:  Iuliana Andreiana; Simona Stancu; Andreea Avram; Ludmila Taran; Gabriel Mircescu
Journal:  BMC Nephrol       Date:  2015-06-30       Impact factor: 2.388

10.  Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine.

Authors:  Clara J Day; Alec J Howie; Peter Nightingale; Shazia Shabir; Dwomoa Adu; Caroline O Savage; Peter Hewins
Journal:  Am J Kidney Dis       Date:  2009-12-31       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.